EU makes 1 billion euro bet on Gilead’s Covid drug before trial results
Pfizer, BioNTech Ink Deal To Supply 1.5M Covid Vaccines To New Zealand
Altimmune's COVID-19 Vaccine Shows Positive Results; Street Sees 289% Upside
3 COVID-19 Antibody Stocks That Are Leading the Race
Niu E-Scooter Sales Jump 68%; Shares Soar 17%
Macro: Tracking the Loss of Momentum
GenMark Pops 13% On Very Strong 3Q, FDA Emergency Clearance
Gilead Inks EU Supply Deal For 500,000 Remdesivir Doses
Peloton Goes Parabolic
WTO Warns 2021 "Could Slow Sharply" After Better-Than-Expected Rebound So Far
GSK, Vir cleared to leap into PhIII, angling for a spot in the Covid-19 antibody race led by Lilly, Regeneron
Asda la Vista: Walmart Sells UK Supermarket Chain, Strategy Remains Intact, Says Analyst
Covid-19 roundup: Top analyst: Regeneron EUA likely this week — unless Trump takes a turn for worse; UK says less than half of residents will be vaccinated
Ford Gains On Impressive 3Q US Auto Sales Data
Regeneron: Initial Data From REGN-COV2 Trial Shows Promise, but Capacity Remains an Issue
Quidel 3Q Sales To Beat The Street Amid Covid-19 Test Demand
Moderna says Covid-19 vaccine unlikely to be ready before U.S. election – FT
Regeneron Up 4% As Covid-19 Cocktail Lowers Viral Levels; Analyst Says Hold
FDA slams brakes on Inovio’s final-stage COVID-19 vaccine trials
SoftBank will bring Bear’s serving robots to Japan, amid restaurant labor shortages
WMT, UNP, LIN Are Leading Dividend Stocks for Investors Preparing for Sector Rotation
American Airlines Gets Upsized $5.5 Billion Loan From US Treasury, Averting 19,000 Furloughs
3 ‘Strong Buy’ Stocks With Over 7% Dividend Yield
Most Americans to be vaccinated for Covid-19 by July 2021, CDC chief expects
FDA’s New Moves Can’t Allay Coronavirus Vaccine Fears
Political interference fears mount as Trump backs Pfizer’s COVID vaccine
Pfizer Reveals Efficacy Criteria For Key Covid-19 Vaccine Trials
Don’t Go Bargain Hunting on Boeing Stock Quite Yet, Says 5-Star Analyst
Pfizer vaccine trial bets on early win against coronavirus, documents show
BioNTech Buys German Site From Novartis To Boost Covid-19 Vaccine Supply